Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future

References

• Atun R, Davies JI, Gale EAM, et al. Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol. 2017;5(8):622–667.
   PubMed Web of Science ®Google Scholar
• Mapa-Tassou C, Katte JC, Mba Maadjhou C, et al. Economic impact of diabetes in Africa. Curr Diab Rep. 2019;19(2):5.
   PubMed Web of Science ®Google Scholar
• WHO. Global report on diabetes. 2016. Available from http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1.
   Google Scholar
• International Diabetes Feceration. IDF Africa members. 2019. [cited 2020 Jan 27]. Available from: https://idf.org/our-network/regions-members/africa/members/25-south-africa.html.
   Google Scholar
• IDF. IDF DIABETES ATLAS Africa. 2019. [cited 2020 Jan 27]. Available from: https://diabetesatlas.org/upload/resources/2019/2019_regional_factsheet.pdf.
   Google Scholar
• Elliot J, Besançon S, Sachs J. Almost 100 years after it was discovered, let’s make access to insulin a reality in Africa! 2016. [cited 2020 Jan 18]. Available from: https://ideas4development.org/en/almost-100-years-after-it-was-discovered-lets-make-access-to-insulin-a-reality-in-africa/.
   Google Scholar
• Godman B, Basu D, Pillay Y, et al. Review of ongoing activities and challenges to improve the care of patients with Type 2 diabetes across Africa and the implications for the future. Frontiers in Pharmacology; 2020;11(108).
   Google Scholar
• Pambou Damiens a, Ganga-Zandzou PS, Tsoucka Ibounde E, et al. Type 1 diabetes mellitus in Gabon: a study of epidemiological aspects. Int J Pediatrics Adolesce Med. 2019;6(3):87–91. .
   PubMedGoogle Scholar
• Hall V, Thomsen RW, Henriksen O, et al. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. a systematic review. BMC Public Health. 2011;11:564.
   PubMed Web of Science ®Google Scholar
• Pastakia SD, Pekny CR, Manyara SM, et al. Diabetes in sub-Saharan Africa - from policy to practice to progress: targeting the existing gaps for future care for diabetes. Diabetes Metab Syndr Obes. 2017;10:247–263.
   PubMed Web of Science ®Google Scholar
• Uloko AE, Ofoegbu EN, Chinenye S, et al. Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocrinol Metab. 2012;16(4):558–564. .
   PubMedGoogle Scholar
• International Diabetes Federation. IDF Atlas ninth edition. 2019. [cited 2020 Jan 20]. Available from: https://diabetesatlas.org/upload/resources/material/20200106_152211_IDFATLAS9e-final-web.pdf.
   Google Scholar
• Niba LL Determinants of outcome of children with type 1 diabetes in the North West Region of Cameroon. 2016. [cited 2020 Jan 17]. Available from: https://edoc.ub.uni-muenchen.de/20100/7/Niba_Loveline.pdf.
   Google Scholar
• Reddy Y, Gannie Y, Pillay K. Characteristics of children presenting with newly diagnosed type1 diabetes. SAJCH. 2013;7(2):46–48c.
   PubMedGoogle Scholar
• Balcha SA, Phillips DIW, Trimble ER. Type 1 diabetes in a resource-poor setting: malnutrition related, malnutrition modified, or just diabetes? Curr Diab Rep. 2018;18(7):47.
   PubMed Web of Science ®Google Scholar
• Marshall SL, Edidin D, Arena VC, et al. Prevalence and incidence of clinically recognized cases of Type 1 diabetes in children and adolescents in Rwanda, Africa. Diabetic Med. 2015;32(9):1186–1192. .
   PubMed Web of Science ®Google Scholar
• Marshall SL, Edidin DV, Arena VC, et al. Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education. Diabetes Res Clin Pract. 2015;107(1):113–122. .
   PubMed Web of Science ®Google Scholar
• Padoa CJ, Rheeder P, Pirie FJ, et al. Identification of a subgroup of black South Africans with type 1 diabetes who are older at diagnosis but have lower levels of glutamic acid decarboxylase and islet antigen 2 autoantibodies. Diabetic Med. 2019. DOI:10.1111/dme.14204
   PubMed Web of Science ®Google Scholar
• Patterson CC, Karuranga S, Salpea P, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.
   PubMed Web of Science ®Google Scholar
• Bahendeka SK. Diabetes in sub-Saharan Africa: let us not forget type 1. Lancet Diabetes Endocrinol. 2017;5(8):575–577.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. IDF ninth edition - country summary table. 2019. Available from: https://diabetesatlas.org/en/resources/.
   Google Scholar
• Jasem D, Majaliwa ES, Ramaiya K, et al. Incidence, prevalence and clinical manifestations at onset of juvenile diabetes in Tanzania. Diabetes Res Clin Pract. 2020;11(108).
   Web of Science ®Google Scholar
• da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al. IDF diabetes atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract. 2016;117:48–54.
   PubMed Web of Science ®Google Scholar
• Pei F Managing diabetes in Urban Ghana: is it affordable? 2015. [cited 2020 Jan 20]. Available from: https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/10014/Pei_duke_0066N_12921.pdf?sequence=1&isAllowed=y.
   Google Scholar
• Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract. 2002;56(3):197–205.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. IDF Africa members - Ghana. 2017. Available from: https://idf.org/our-network/regions-members/africa/members/11-ghana.html.
   Google Scholar
• IDF. Middle East and North Africa. 2019. [cited 2020 Jan 17]. Available from: https://idf.org/our-network/regions-members/middle-east-and-north-africa/members/41-morocco.html. Accessed 17 January 2020
   Google Scholar
• Dinar Y, Belahsen R. Diabetes mellitus in Morocco: situation and challenges of diabetes care. J Sci Res Rep. 2014;3(19):2477–2485.
   Google Scholar
• Chetoui a, Kaoutar K, Kardoudi a, et al. Epidemiology of diabetes in Morocco: review of data, analysis and perspectives. Int J Sci Eng Res. 2018;9(12):1310–1316.
   Google Scholar
• Adekanmbi VT, Uthman OA, Erqou S, et al. Epidemiology of prediabetes and diabetes in Namibia, Africa: a multilevel analysis. J Diabetes. 2019;11(2):161–172.
   PubMed Web of Science ®Google Scholar
• Ugege O, Ibitoye PK, Jiya NM. Childhood diabetes mellitus in sokoto, north-western Nigeria: a ten year review. Sahel Med J. 2013;16:97–101.
   Google Scholar
• Adeleke SI, Asani MO, Belonwu RO, et al. Childhood diabetes mellitus in Kano, North West, Nigeria. Niger J Med. 2010;19(2):145–147.
   PubMedGoogle Scholar
• Ibekwe MU, Ibekwe RC. Pattern of Type 1 diabetes mellitus in Abakaliki, Southeastern, Nigeria. Pediatr Oncall J. 2011;8:59–62.
   Google Scholar
• Umar UI. Pattern of presentation of Type 1 diabetic patients in Kano, Nigeria. Niger J Basic Clin Sci. 2016;13:85–88.
   Google Scholar
• John C, Abok II, Yilgwan C. Clinical profile of childhood type 1 diabetes in Jos, Nigeria. AfrJ Diabetes Med. 2013;21(1):11–13.
   Google Scholar
• de Dieu NJ. Diabetes prevalence in Rwanda at 3% – moH. 2019. [cited 2020 Jan 26]. Available from: https://www.newtimes.co.rw/news/diabetes-prevalence-rwanda-3-moh.
   Google Scholar
• Mutyambizi C, Booysen F, Stokes a, et al. Lifestyle and socio-economic inequalities in diabetes prevalence in South Africa: a decomposition analysis. PloS One. 2019;14(1):e0211208.
   PubMed Web of Science ®Google Scholar
• Ekpebegh CO, Longo-Mbenza B. Clinical, immunologic and insulin secretory characteristics of young black South African patients with diabetes: hospital based single centre study. Diabetes Res Clin Pract. 2013;99(3):380–384.
   PubMed Web of Science ®Google Scholar
• Elamin A, Ghalib M, Eltayeb B, et al. High incidence of type 1 diabetes mellitus in Sudanese children, 1991-1995. Ann Saudi Med. 1997;17(4):478–480.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Country profile - Zambia. 2019. [cited 2020 Feb 3]. Available from: https://www.who.int/diabetes/country-profiles/zmb_en.pdf?ua=1.
   Google Scholar
• Mutowo M, Gowda U, Mangwiro JC, et al. Prevalence of diabetes in Zimbabwe: a systematic review with meta-analysis. Int J Public Health. 2015;60(1):1–11.
   PubMed Web of Science ®Google Scholar
• Pirie FJ, Pegoraro R, Motala AA, et al. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens. 2005;66(2):125–130. .
   PubMedGoogle Scholar
• Piloya-Were T, Sunni M, Ogle GD, et al. Childhood diabetes in Africa. Curr Opin Endocrinol Diabetes Obes. 2016;23(4):306–311.
   PubMed Web of Science ®Google Scholar
• Chikani UN, Bisi-Onyemaechi AI, Oguonu T, et al. Childhood diabetes: a myth or reality?- perception of the public from a low-income country: a cross-sectional study. BMC Public Health. 2018;18(1):852.
   PubMedGoogle Scholar
• Panz VR, Kalk WJ, Zouvanis M, et al. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa. Diabetic Med. 2000;17(7):524–527.
   PubMed Web of Science ®Google Scholar
• Fasanmade OA, Dagogo-Jack S. Diabetes care in Nigeria. Ann Glob Health. 2015;81(6):821–829.
   PubMed Web of Science ®Google Scholar
• Ogbera AO, Fasanmade O, Ohwovoriole AE, et al. An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 2006;5(4):244–249.
   PubMedGoogle Scholar
• Quaye EA, Amporful EO, Akweongo P, et al. Analysis of the financial cost of diabetes mellitus in Four Cocoa Clinics of Ghana. Value Health Reg Issues. 2015;7:49–53.
   PubMedGoogle Scholar
• Suleiman IA, Festus JA. Cost of illness among diabetes mellitus patients in Niger Delta, Nigeria. J Pharm Health Serv Res. 2015;6(1):53–60.
   Google Scholar
• Mutale W, Bosomprah S, Shankalala P, et al. Assessing capacity and readiness to manage NCDs in primary care setting: gaps and opportunities based on adapted WHO PEN tool in Zambia. PloS One. 2018;13(8):e0200994–e. .
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Social Services, Primary Health Care Directorate, Namibia. National multisectoral strategic plan for prevention and control of Non-Communicable Diseases (NCDs) in Namibia 2017/18 – 2021/22. 2017. [cited 2020 Jan 15]. Available from: https://www.iccp-portal.org/system/files/plans/NAMIBIA%20NATIONAL%20MULTISECTORAL%20STRATEGIC%20PLAN%20FOR%20PREVENTION%20AND%20CONTROL%20OF%20NCDs.pdf.
   Google Scholar
• Mukanu MM, Zulu JM, Mweemba C, et al. Responding to non-communicable diseases in Zambia: a policy analysis. Health Res Policy Syst. 2017;15(1):34.
   PubMedGoogle Scholar
• Federal Ministry of Health, SIDCAIN, World Diabetes Foundation. Diabetes and NCDs in Nigeria - perspectives, challenges & the way forward. 2017. [cited 2020 Jan 18]. Available from: http://sidcain.org/download/ABUJA%20Proceedings%20Reviewed%20Nov%202017.pdf.
   Google Scholar
• NDOH. National department of health republic of South Africa. Adherence guidelines for HIV, TB and NCDs. Policy and service delivery guidelines to care, adherence to treatment and retention in care. February 2016. [cited 2020 Feb 5]. Available from: https://www.nacosa.org.za/wp-content/uploads/2016/11/Integrated-Adherence-Guidelines-NDOH.pdf
   Google Scholar
• Kingdom of Eswatini - Ministry of Health. NATIONAL PREVENTION AND CONTROL OF NON COMMUNICABLE DISEASES (NCDs). 2017 Annual Program Report; 2017.
   Google Scholar
• Igbojiaku OJ, Harbor OC, Ross a. Compliance with diabetes guidelines at a regional hospital in KwaZulu-Natal, South Africa. Afr J Prim Health Care Fam Med. 2013;5(1):447.
   Google Scholar
• SEMDSA. 2017 Guidelines for the management of Type 2 diabetes mellitus. SEMDSA Type 2 diabetes guidelines expert committee. JEMDSA. 2017;22(1)(Supplement1):S1–S196.
   Google Scholar
• Awodele O, Osuolale JA. Medication adherence in type 2 diabetes patients: study of patients in alimosho general hospital, Igando, Lagos, Nigeria. Afr Health Sci. 2015;15(2):513–522.
   PubMed Web of Science ®Google Scholar
• Botswana national multisectoral strategy for the prevention and control of non-communicable diseases. 2017. [cited 2020 Jan 17]. Available from: https://www.iccp-portal.org/system/files/plans/20171129%20Botswana%20multisec%20NCDs%20strategy%20-%20final.pdf.
   Google Scholar
• Khogali SS, Ali WA, Mohamed SY, et al. Knowledge, attitude and practice of Sudanese individuals with type 2 diabetes about medication used in treatment of diabetes, hypertension and dyslipidaemia: a matter of debate or matter of concern? J Public Health Emerg. 2018;2:23.
   Google Scholar
• Shannon GD, Haghparast-Bidgoli H, Chelagat W, et al. Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project. Glob Health Action. 2019;12(1):1605704.
   PubMed Web of Science ®Google Scholar
• International Insulin Foundation – Fact Sheet on diabetes in sub-Saharan Africa. [cited 2020 Jan 20]. Available from: http://www.access2insulin.org/uploads/4/9/1/0/4910107/factsheet.pdf.
   Google Scholar
• Djonou C, Tankeu AT, Dehayem MY, et al. Glycemic control and correlates in a group of sub Saharan type 1 diabetes adolescents. BMC Res Notes. 2019;12(1):50.
   PubMed Web of Science ®Google Scholar
• Balde N, Camara a, Sobngwi-Tambekou J, et al. Improving access to HbA1c in sub-Saharan Africa (IA3) cohort: cohort profile. Pan Afr Med J. 2017;27:275.
   PubMed Web of Science ®Google Scholar
• Park PH, Pastakia SD. Access to hemoglobin A1c in rural Africa: a difficult reality with severe consequences. J Diabetes Res. 2018;2018:6093595.
   PubMed Web of Science ®Google Scholar
• Republic of Zambia. Ministry of Health. Zambia national health strategic plan 2017–2021. Lusaka; 2017. [cited 2020 Jan 20]. Available from: https://www.moh.gov.zm/docs/ZambiaNHSP.pdf
   Google Scholar
• Tapela NM, Tshisimogo G, Shatera BP, et al. Integrating noncommunicable disease services into primary health care, Botswana. Bull World Health Organ. 2019;97(2):142–153. .
   PubMed Web of Science ®Google Scholar
• WHO Africa. The team Type 1 foundation and abbott partner to donate glucose meters and nearly 12 million test strips to help people living with diabetes in Rwanda. 2020. [cited 2020 Jan 20]. Available from: https://www.afro.who.int/news/team-type-1-foundation-and-abbott-partner-donate-glucose-meters-and-nearly-12-million-test. Accessed 20 January 2020
   Google Scholar
• Kenya Ministry of Health. Transforming health: accelerating attainment of universal health coverage. The KENYA HEALTH SECTOR STRATEGIC AND INVESTMENT PLAN – KHSSP July 2012 –June; 2017. [cited 2020 Jan 18]. Available from: http://e-cavi.com/wp-content/uploads/2014/11/kenya-health-sector-strategic-investiment-plan-2013-to-2017.pdf Accessed 20 January 2020
   Google Scholar
• Rampamba EM, Meyer JC, Helberg EA, et al. Empowering hypertensive patients in south Africa to improve their disease management: a pharmacist-led intervention. J Res Pharm Pract. 2019;8(4):208–213.
   PubMed Web of Science ®Google Scholar
• Atkilt HS, Turago MG, Tegegne BS. Clinical characteristics of diabetic ketoacidosis in children with newly diagnosed Type 1 diabetes in Addis Ababa, Ethiopia: a cross-sectional study. PloS One. 2017;12(1):e0169666–e.
   PubMed Web of Science ®Google Scholar
• Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343.
   PubMed Web of Science ®Google Scholar
• Azevedo M, Alla S. Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia. Int J Diabetes Dev Countries. 2008;28(4):101–108.
   PubMed Web of Science ®Google Scholar
• Onyiriuka AN, Ifebi E. Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: frequency and clinical characteristics. J Diabetes Metab Disord. 2013;12(1):47.
   PubMedGoogle Scholar
• Murunga AN, Owira PM. Diabetic ketoacidosis: an overlooked child killer in sub-Saharan Africa? Trop Med Int Health. 2013;18(11):1357–1364.
   PubMed Web of Science ®Google Scholar
• Ndebele NFM, Naidoo M. The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal. Afr J Prim Health Care Fam Med. 2018;10(1):e1–e6.
   PubMed Web of Science ®Google Scholar
• Majaliwa ES, Mohn a, Chiavaroli V, et al. Management of diabetic ketoacidosis in children and adolescents in sub-Saharan Africa: a review. East Afr Med J. 2010;87(4):167–173.
   PubMedGoogle Scholar
• Iovane B, Cangelosi AM, Bonaccini I, et al. Diabetic ketoacidosis at the onset of Type 1 diabetes in young children is it time to launch a tailored campaign for DKA prevention in children. Acta Biomed. 2018;89(1):67–71. .
   PubMedGoogle Scholar
• Van Zyl DG. Diagnosis and treatment of diabetic ketoacidosis. S Afr Family Pract. 2008;50(1):35–39.
   Google Scholar
• Ngwiri T, Were F, Predieri B, et al. Glycemic Control in Kenyan children and adolescents with Type 1 diabetes mellitus. Int J Endocrinol. 2015;2015:761759.
   PubMed Web of Science ®Google Scholar
• Mukama LJ, Moran a, Nyindo M, et al. Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania. Pediatr Diabetes. 2013;14(3):211–216.
   PubMed Web of Science ®Google Scholar
• Emral R, Pathan F, Cortés CAY, et al. Self-reported hypoglycemia in insulin-treated patients with diabetes: results from an international survey on 7289 patients from nine countries. Diabetes Res Clin Pract. 2017;134:17–28.
   PubMed Web of Science ®Google Scholar
• Kalweit KL, Briers N, Olorunju S. The success of various management techniques used in South African children with type 1 diabetes mellitus. S Afr Med J. 2015;105(5):400–404.
   PubMedGoogle Scholar
• Fulcher G, Singer J, Castañeda R, et al. The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. J Med Econ. 2014;17(10):751–761. .
   PubMedGoogle Scholar
• Muddu M, Mutebi E, Ssinabulya I, et al. Hypertension among newly diagnosed diabetic patients at Mulago national referral hospital in Uganda: a cross sectional study. Cardiovasc J Afr. 2018;29(4):218–224.
   PubMed Web of Science ®Google Scholar
• Ahmed SA, Badi S, Tahir H, et al. Knowledge and practice of diabetic foot care in Sudan: a cross sectional survey. Diabetes Metab Syndr. 2019;13(4):2431–2435.
   PubMed Web of Science ®Google Scholar
• Wagnew F, Eshetie S, Kibret GD, et al. Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis. BMC Res Notes. 2018;11(1):565. .
   PubMedGoogle Scholar
• Hapunda G, Abubakar a, van de Vijver F, et al. Living with type 1 diabetes is challenging for Zambian adolescents: qualitative data on stress, coping with stress and quality of care and life. BMC Endocr Disord. 2015;15:20.
   PubMed Web of Science ®Google Scholar
• Rwegerera GM, Moshomo T, Gaenamong M, et al. Health-related quality of life and associated factors among patients with diabetes mellitus in Botswana. Alexandria J Med. 2018;54(2):111–118. .
   Web of Science ®Google Scholar
• da Mata AR, Alvares J, Diniz LM, et al. Quality of life of patients with diabetes mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil. Expert Rev Clin Pharmacol. 2016;9(5):739–746. .
   PubMed Web of Science ®Google Scholar
• Nieuwesteeg a, Pouwer F, van der Kamp R, et al. Quality of life of children with type 1 diabetes: a systematic review. Curr Diabetes Rev. 2012;8(6):434–443.
   PubMedGoogle Scholar
• Oluyombo R, Okunola OO, Olanrewaju TO, et al. Challenges of hemodialysis in a new renal care center: call for sustainability and improved outcome. Int J Nephrol Renovasc Dis. 2014;7:347–352.
   PubMedGoogle Scholar
• Makhele L, Matlala M, Sibanda M, et al. a Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa. Pharmacoecon Open. 2019;3(4):631-41.
   Web of Science ®Google Scholar
• Beran D, Hirsch IB, Yudkin JS. Why Are We Failing to Address the Issue of Access to Insulin? a National and Global Perspective. Diabetes Care. 2018;41(6):1125–1131.
   PubMed Web of Science ®Google Scholar
• Mansfield J TYPE 1 DIABETES IN GHANA: a GLOBAL COMMUNITY DISCUSSION. 2018. [cited 2020 Jan 20]. Available from: https://beyondtype1.org/type-1-diabetes-ghana/.
   Google Scholar
• Pirie FJ, Jairam V, Paruk IM, et al. High frequency of hypoglycaemia in patients with type 1 diabetes mellitus attending a tertiary diabetes clinic in Durban, South Africa. Diabetes Res Clin Pract. 2019;155:107783.
   PubMed Web of Science ®Google Scholar
• Beran D, Ewan M, Laing R Access to insulin - Current Challenges & Constraints. October 2015. [cited 2020 Jan 19]. Available from: https://apps.who.int/medicinedocs/documents/s22269en/s22269en.pdf.
   Google Scholar
• Ewen M, Joosse HJ, Beran D, et al. Insulin prices, availability and affordability in 13 low-income and middle-income countries. BMJ Glob Health. 2019;4(3):e001410.
   PubMed Web of Science ®Google Scholar
• Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016;4(3):275–285.
   PubMed Web of Science ®Google Scholar
• Beran D, Laing RO, Kaplan W, et al. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices. Diabetic Med. 2019;36(6):726–733. .
   PubMed Web of Science ®Google Scholar
• Tiruneh GG, Abebe N, Dessie G. Self-reported hypoglycemia in adult diabetic patients in East Gojjam, Northwest Ethiopia: institution based cross-sectional study. BMC Endocr Disord. 2019;19(1):17.
   PubMedGoogle Scholar
• Kahsay H, Fantahun B, Nedi T, et al. Evaluation of Hypoglycemia and Associated Factors among Patients with Type 1 Diabetes on Follow-Up Care at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. J Diabetes Res. 2019;2019:9037374.
   PubMed Web of Science ®Google Scholar
• Kratzer J. Structural barriers to coping with type 1 diabetes mellitus in Ghana: experiences of diabetic youth and their families. Ghana Med J. 2012;46(2 Suppl):39–45.
   PubMedGoogle Scholar
• TiInternational. Ghana. [cited 2020 Jan 20]. Available from: https://www.t1international.com/Ghana/.
   Google Scholar
• World Health Organisation (WHO). Global action Plan for the prevention and control of noncommunicable diseases. 2013. [cited 2020 Jan 18]. Available from: https://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf;jsessionid=7E6647ED415CFBF876A7CC201127FB76?sequence=1.
   Google Scholar
• Kapwata T, Manda S. Geographic assessment of access to health care in patients with cardiovascular disease in South Africa. BMC Health Serv Res. 2018;18(1):197.
   PubMedGoogle Scholar
• Sandoz - a Novartis Division. Kenya is first country to launch ‘Novartis Access’, expanding affordable treatment options against chronic diseases. 2015. [cited 2020 Jan 18]. Available from: https://www.sandoz.com/news/media-releases/kenya-first-country-launch-novartis-access-expanding-affordable-treatment.
   Google Scholar
• Kabeza CB, Harst L, Schwarz PEH, et al. Assessment of Rwandan diabetic patients’ needs and expectations to develop their first diabetes self-management smartphone application (Kir’App). Ther Adv Endocrinol Metab. 2019;10:2042018819845318.
   Web of Science ®Google Scholar
• Novo Nordisk. NOVO NORDISK EXPANDS PROGRAMME TO REACH 20,000 CHILDREN WITH DIABETES IN DEVELOPING COUNTRIES. 2016. [cited 2020 Jan 19]. Available from: http://www.multivu.com/players/uk/7962351-novo-nordisk-programme-children-diabetes/.
   Google Scholar
• Roche. Changing diabetes care for children in Africa. 2019. [cited 2020 Jan 22]. Available from: https://www.roche.com/sustainability/access-to-healthcare/ath_diabetes.htm.
   Google Scholar
• Pillay DK, Ross AJ, Campbell L. A review of hypoglycaemia in a South African family practice setting. Afr J Prim Health Care Fam Med. 2016;8(1):e1–e6.
   PubMed Web of Science ®Google Scholar
• Kaplan H, Amodb a, van Zyk FH, et al. Incidence of hypoglycaemia in the South African population with diabetes: results from the IDMPS Wave 7 study. J Endocrinol Metabolism Diabetes South Afr. 2019;24(2):58–64.
   Web of Science ®Google Scholar
• WHO. World health organization model list of essential medicines 2019. [cited 2020 Jan 20]. Available from: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=21stList 201.
   Google Scholar
• Ogle GD, Kim H, Middlehurst AC, et al. Financial costs for families of children with Type 1 diabetes in lower-income countries. Diabetic Med. 2016;33(6):820–826.
   PubMed Web of Science ®Google Scholar
• Ogle GD, Middlehurst AC, Silink M. The IDF life for a child program index of diabetes care for children and youth. Pediatr Diabetes. 2016;17(5):374–384.
   PubMed Web of Science ®Google Scholar
• Silver B, Ramaiya K, Andrew SB, et al. EADSG guidelines: insulin therapy in diabetes. Diabetes Therapy. 2018;9(2):449–492. .
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293–301. .
   PubMed Web of Science ®Google Scholar
• Sherif S, Sumpio BE. Economic development and diabetes prevalence in MENA countries: Egypt and Saudi Arabia comparison. World J Diabetes. 2015;6(2):304–311.
   PubMed Web of Science ®Google Scholar
• Pastakia SD, Nuche-Berenguer B, Pekny CR, et al. Retrospective assessment of the quality of diabetes care in a rural diabetes clinic in Western Kenya. BMC Endocr Disord. 2018;18(1):97. .
   PubMedGoogle Scholar
• Matheka DM, Kilonzo JM, Munguti CM, et al. Pattern, knowledge and practices of HbA1C testing among diabetic patients in a Kenyan tertiary referral hospital. Global Health. 2013;9:55.
   PubMed Web of Science ®Google Scholar
• Mbui JM, Oluka MN, Guantai EM, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1263–1271. .
   PubMed Web of Science ®Google Scholar
• Nashilongo MM, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–578. .
   PubMed Web of Science ®Google Scholar
• Fadare J, Olamoyegun M, Gbadegesin BA. Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Med J. 2015;27(2):65–70.
   PubMed Web of Science ®Google Scholar
• Mutyambizi C, Pavlova M, Chola L, et al. Cost of diabetes mellitus in Africa: a systematic review of existing literature. Global Health. 2018;14(1):3.
   PubMed Web of Science ®Google Scholar
• Ogbera AO, Kuku SF. Insulin use, prescription patterns, regimens and costs.-a narrative from a developing country. Diabetol Metab Syndr. 2012;4(1):50.
   PubMedGoogle Scholar
• Onyiriuka N, Ezomo OO, Onyiriuka RC. Cost of treating insulin-requiring diabetes in children and adolescents. J Inst Med. 2012;34(1):2–8.
   Google Scholar
• Yamey G, Fewer S, Beyeler N. Achieving a “grand convergence” in global health by 2035: Rwanda shows the way comment on “improving the world’s health through the post-2015 development agenda: perspectives from Rwanda”. Int J Health Policy Manag. 2015;4(11):789–791.
   PubMed Web of Science ®Google Scholar
• Rwanda Diabetes Association. 2019. [cited 2020 Feb 8]. Available from: https://rwandadiabetes.com/.
   Google Scholar
• The Global Fund. Global fund grants in the republic of Sudan - GF-OIG-19-010. Geneva, Switzerland. 2019. [cited 2020 Feb 3]. Available from: https://www.theglobalfund.org/media/8433/oig_gf-oig-19-010_report_en.pdf?u=637066540330000000.
   Google Scholar
• Mohamed Ali GK. 3,121 days in the driving seat of the national medical supplies fund: what lessons to be shared? Book manuscript under proofreading for publication.
   Google Scholar
• Elrayah H, Eltom M, Bedri a, et al. Economic burden on families of childhood type 1 diabetes in urban Sudan. Diabetes Res Clin Pract. 2005;70(2):159–165.
   PubMed Web of Science ®Google Scholar
• Eliadarous H. Exploring the impact of diabetes in Sudan: out-of-pocket expenditure and social consequences of diabetes on patients and their families. Stockholm, Sweden; 2017. [cited 2020 Jan 17]. Available from: https://openarchive.ki.se/xmlui/bitstream/handle/10616/45956/Thesis_Hind_Eliadarous.pdf?sequence=1&isAllowed=y
   Google Scholar
• Peck R, Mghamba J, Vanobberghen F, et al. Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey. Lancet Glob Health. 2014;2(5):e285–e92. .
   PubMed Web of Science ®Google Scholar
• Kalungia CA, Mwale M, Sondashi IS, et al. Availability of essential antihypertensive and antidiabetic medicines in public health facilities in Lusaka District, Zambia. Med J Zambia. 2017;44(3):140–148.
   Google Scholar
• Kaiser AH, Hehman L, Forsberg BC, et al. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia. PloS One. 2019;14(12):e0226169–e.
   PubMed Web of Science ®Google Scholar
• Moucheraud C, Lenz C, Latkovic M, et al. The costs of diabetes treatment in low– and middle–income countries: a systematic review. BMJ global health.. 2019;4(1):e001258.
   Google Scholar
• Jaam M, Ibrahim MIM, Kheir N, et al. Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: a systematic mixed studies review. Diabetes Res Clin Pract. 2017;129:1–15.
   PubMed Web of Science ®Google Scholar
• Majaliwa ES, Elusiyan BE, Adesiyun OO, et al. Type 1 diabetes mellitus in the African population: epidemiology and management challenges. Acta Biomed. 2008;79(3):255–259.
   PubMedGoogle Scholar
• Manne-Goehler J, Geldsetzer P, Agoudavi K, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med. 2019;16(3):e1002751. .
   PubMed Web of Science ®Google Scholar
• Owolabi MO, Yaria JO, Daivadanam M, et al. Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review. Diabetes Care. 2018;41(5):1097–1105. .
   PubMed Web of Science ®Google Scholar
• Godman B, Haque M, McKimm J, et al. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Curr Med Res Opin. 2020;36(2):301–327. .
   PubMed Web of Science ®Google Scholar
• Godman B, Wettermark B, van Woerkom M, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Front Pharmacol. 2014;5:106.
   PubMed Web of Science ®Google Scholar
• Godman B, Malmstrom RE, Diogene E, et al. Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs. Front Pharmacol. 2014;5:109.
   PubMed Web of Science ®Google Scholar
• Godman B, Malmstrom RE, Diogene E, et al. Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? Expert Rev Clin Pharmacol. 2015;8(1):77–94. .
   PubMed Web of Science ®Google Scholar
• Godman B, Bucsics a, Vella Bonanno P, et al. Barriers for access to new medicines: searching for the balance between rising costs and limited budgets. Front Public Health. 2018;6:328.
   PubMed Web of Science ®Google Scholar
• Ermisch M, Bucsics a, Vella Bonanno P, et al. Payers‘ views of the changes arising through the possible adoption of adaptive pathways. Front Pharmacol. 2016;7:305.
   PubMed Web of Science ®Google Scholar
• Godman B, Grobler C, Van-De-Lisle M, et al. Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opin Pharmacother. 2019;20(18):2237–2255. .
   PubMed Web of Science ®Google Scholar
• Moorkens E, Vulto AG, Huys I, et al. Policies for biosimilar uptake in Europe: an overview. PloS One. 2017;12(12):e0190147.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. [cited 2020 Jan 22]. Available from: https://apps.who.int/iris/bitstream/handle/10665/43588/9241594934_eng.pdf;jsessionid=75A0C3B74F6572D012AB00D9F8A23D4E?sequence=1.
   Google Scholar
• WHO. Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus. 2018. [cited 2020 Jan 18]. Available from: https://apps.who.int/iris/bitstream/handle/10665/272433/9789241550284-eng.pdf?ua=1.
   Google Scholar
• Beran D, Ewen M, Lipska K, et al. Availability and affordability of essential medicines: implications for global diabetes treatment. Curr Diab Rep. 2018;18(8):48.
   PubMed Web of Science ®Google Scholar
• Ghana National Health Insurance Medicine list 2018. Avaiable from: http://www.nhis.gov.gh/files/2018%20NHIS%20ML.pdf.
   Google Scholar
• Government of the Kingdom of Swaziland Ministry of Health, the US President’s Emergency Plan for AIDS Relief, USAID, and Strengthening Pharmaceutical Systems (SPS) Program. Standard treatment guidelines and essential medicines list of common medical conditions in the kingdom of Swaziland. 2012. [cited 2020 Jan 20]. Available from: https://apps.who.int/medicinedocs/documents/s22119en/s22119en.pdf.
   Google Scholar
• Kalk WJ, Raal J, Joffe BI. The prevalence and incidence of and risk factors for, micro-albuminuria among urban Africans with type 1 diabetes in South Africa: an inter-ethnic study. Int J Diabetes Mellitus. 2010;2:148–153.
   Google Scholar
• Diabetes South Africa. The Tshwane insulin project. 2018. [cited 2020 Jan 18]. Available from: https://www.diabetessa.org.za/the-tshwane-insulin-project/.
   Google Scholar
• Ntuli C Tuks sets up diabetes treatment programme. 2019. [cited 2020 Feb 9]. Available from: https://www.iol.co.za/pretoria-news/tuks-sets-up-diabetes-treatment-programme-37175398.
   Google Scholar
• Federal Ministry of Health, Sudan. National essential medicines list, 2014. [cited 2020 Jan 20]. Available from: https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/sudan_national_essential_medicines_list_.pdf.
   Google Scholar
• Jonker D, Deacon E, van Rensburg E, et al. Illness perception of adolescents with well-controlled type 1 diabetes mellitus. Health Psychol Open. 2018;5(2):2055102918799968.
   Web of Science ®Google Scholar
• Roth GA, Johnson C, Abajobir a, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. .
   PubMed Web of Science ®Google Scholar
• Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677–694. .
   PubMed Web of Science ®Google Scholar
• Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in. 188 countries: an analysis from the global burden of disease study 2016. Lancet. 2017;390(10100):1423–1459. .
   PubMed Web of Science ®Google Scholar
• United Nations. Sustainable development goal 3 - ensure healthy lives and promote well-being for all at all ages. 2019. [cited 2020 Feb 3]. Available from: https://sustainabledevelopment.un.org/sdg3.
   Google Scholar
• Morton S, Pencheon D, Squires N. Sustainable Development Goals (SDGs), and their implementation: a national global framework for health, development and equity needs a systems approach at every level. Br Med Bull. 2017;124(1):81–90.
   PubMed Web of Science ®Google Scholar
• Caires de Souza AL, de Assis Acurcio F, Guerra AA Junior, et al. Insulin glargine in a Brazilian state: should the government disinvest? An assessment based on a systematic review. Appl Health Econ Health Policy. 2014;12(1):19–32.
   PubMedGoogle Scholar
• de Souza AL, Acurcio Fde a, Guerra Junior AA, et al. Authors’ reply to Dr. Malerbi: “Insulin glargine in a Brazilian state: should the government disinvest?”. Appl Health Econ Health Policy. 2014;12(5):561–563.
   PubMedGoogle Scholar
• Almeida P, Silva TBC, de Assis Acurcio F, et al. Quality of life of patients with Type 1 diabetes mellitus using insulin analog glargine compared with NPH insulin: a systematic review and policy implications. Patient. 2018;11(4):377–389. .
   PubMedGoogle Scholar
• Marra LP, Araujo VE, Silva TB, et al. Clinical effectiveness and safety of analog glargine in Type 1 diabetes: a systematic review and meta-analysis. Diabetes Therapy. 2016;7(2):241–258. .
   PubMed Web of Science ®Google Scholar
• Institut für qualität und Wirtschaftlichkeit im Gesundheitswesen [Institute of quality and efficiency in health care]: long-acting insulin analogues in the treatment of diabetes mellitus type 1. 2010. Available from: http://www.iqwig.de/download/A05-01_Executive-Summary_Long-acting_insulin_analogues_in_diabetes_mellitus_type_1.pdf
   Google Scholar
• Holden SE, Poole CD, Morgan CL, et al. Evaluation of the incremental cost to the national health service of prescribing analogue insulin. BMJ Open. 2011;1(2):e000258.
   PubMed Web of Science ®Google Scholar
• Horvath K, Jeitler K, Berghold a, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;2007(2):Cd005613.
   Google Scholar
• Singh SR, Ahmad F, Lal a, et al. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ. 2009;180(4):385–397.
   PubMed Web of Science ®Google Scholar
• Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. a meta-analysis. Diabetes Obes Metab. 2009;11(4):372–378.
   PubMed Web of Science ®Google Scholar
• NICE. Type 1 diabetes in adults: diagnosis and management NICE guideline [NG17]. 2016. Available from: https://www.nice.org.uk/guidance/ng17.
   Google Scholar
• Moodie P. More from PHARMAC on long-acting insulin analogues: insulin glargine now funded. N Z Med J. 2006;119(1236):U2040–U.
   PubMedGoogle Scholar
• Meyer JC, Schellack N, Stokes J, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; A preliminary study. Front Pharmacol. 2017;8:751.
   PubMed Web of Science ®Google Scholar